A Glimpse of Conmed's Earnings Potential

Conmed (NYSE:CNMD) is gearing up to announce its quarterly earnings on Wednesday, 2026-01-28. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Conmed will report an earnings per share (EPS) of $1.32.

Conmed bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Overview of Past Earnings

Last quarter the company beat EPS by $0.03, which was followed by a 0.52% drop in the share price the next day.

Here's a look at Conmed's past performance and the resulting price change:

Quarter

Q3 2025

Q2 2025

Q1 2025

Q4 2024

EPS Estimate

1.05

1.13

0.81

1.20

EPS Actual

1.08

1.15

0.95

1.34

Price Change %

-1.00

2.00

16.00

-9.00

Market Performance of Conmed's Stock

Shares of Conmed were trading at $40.98 as of January 26. Over the last 52-week period, shares are down 44.0%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

Analyst Opinions on Conmed

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Conmed.

Analysts have provided Conmed with 4 ratings, resulting in a consensus rating ...